Status:
UNKNOWN
Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China
Lead Sponsor:
Southwest Hospital, China
Conditions:
Hepatopulmonary Syndrome
Eligibility:
All Genders
18-80 years
Brief Summary
to investigate the prevalence of hepatopulmonary syndrome in cirrhosis patients caused by Hepatitis B in western China
Detailed Description
Hepatopulmonary syndrome (HPS) occurs in approximately 4%-29% of cirrhotic patients and influences mortality. China has 100 million Hepatitis B virus (HBV) carriers and Chronic HBV infection is well-r...
Eligibility Criteria
Inclusion
- Age: 18-80 years old;
- American association of anesthesiologists(ASA) score: I-III;
- Ability to comply with research programmes;
- Voluntary participation in the study;
- Has the history of HBV infection;
- No primary cardiopulmonary disease (heart disease, emphysema, pneumonia, asthma, etc.)
Exclusion
- Severe heart, lung, kidney disease coexisted;
- American association of anesthesiologists(ASA) score≥IV; forced expiratory volume at one second (FEV1) or forced vital capacity (FVC) \<70%, or FEV1 / FVC \<0.70;
- Mental state could not cooperate
- Absence of written informed consent.
Key Trial Info
Start Date :
July 27 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03435406
Start Date
July 27 2017
End Date
April 1 2018
Last Update
February 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, Southwest Hospital Third Military Medical University
Chongqing, Chongqing Municipality, China, 400038